tradingkey.logo
tradingkey.logo
Search

Processa Pharmaceuticals Inc

PCSA
Add to Watchlist
2.130USD
+0.090+4.41%
Close 07-31 16:00ETQuotes delayed by 15 min
5.70MMarket Cap
LossP/E TTM

PCSA Financials

See Processa Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Processa Pharmaceuticals Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-1.29/-1.00
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-10.36
89.30%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-332.73%-1.29
-91.47%-1.49
-74.97%-1.81
74.96%-0.25
73.08%-0.30
54.47%-0.78
33.00%-1.03
47.98%-1.01
68.71%-1.11
89.20%-1.71
---1.54
---1.94
---3.53
---15.81
---18.02
----
----
----
----
----
Net Profit
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
77.83%-3.18M
2.74%-2.99M
-330.46%-3.16M
Debt to assets ratio
----
----
----
-63.32%0.05%
-3.98%0.11%
--0.20%
--0.16%
--0.13%
--0.11%
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-17.01%-3.33M
-35.37%-3.70M
-1.87%-3.49M
-28.19%-3.95M
-1.33%-2.85M
-10.74%-2.73M
-58.00%-3.42M
-13.54%-3.08M
31.57%-2.81M
57.42%-2.47M
64.21%-2.17M
47.51%-2.71M
-27.16%-4.11M
-72.15%-5.80M
-97.91%-6.06M
-75.66%-5.17M
-47.21%-3.23M
8.78%-3.37M
-220.29%-3.06M
-267.11%-2.94M
Net Profit
-19.15%-3.38M
-23.10%-3.36M
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
81.52%-2.40M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-308.70%-13.01M
-101.54%-6.02M
-63.58%-5.16M
-53.71%-3.23M
77.83%-3.18M
2.74%-2.99M
-330.46%-3.16M
Current assets
-48.42%1.94M
202.67%5.67M
36.14%6.59M
-4.33%7.15M
-61.66%3.76M
-66.74%1.87M
-38.82%4.84M
-24.44%7.48M
-19.80%9.80M
-32.84%5.63M
-27.37%7.91M
-29.11%9.90M
-25.42%12.22M
-54.24%8.39M
-47.33%10.89M
-38.13%13.96M
-33.25%16.38M
13.11%18.33M
5399.00%20.67M
3812.00%22.57M
Total current liabilities
54.34%1.98M
45.91%2.24M
43.62%1.75M
33.70%2.07M
26.94%1.28M
109.78%1.53M
47.59%1.22M
88.90%1.55M
-53.23%1.01M
-26.84%730.58K
-30.74%826.07K
-47.72%821.41K
104.28%2.16M
2.84%998.56K
-2.75%1.19M
35.30%1.57M
-3.46%1.06M
-20.47%971.02K
-53.86%1.23M
-38.82%1.16M
Total assets
-6.00%4.52M
141.96%7.81M
53.47%7.58M
7.64%8.18M
-51.64%4.81M
-44.19%3.23M
-38.86%4.94M
-24.67%7.60M
-20.01%9.94M
-32.87%5.79M
-56.55%8.08M
-53.41%10.09M
-48.84%12.43M
-67.43%8.62M
-35.90%18.60M
-30.45%21.66M
-27.11%24.30M
4.95%26.46M
202.69%29.03M
211.02%31.14M
Total liabilities
54.34%1.98M
45.86%2.24M
43.36%1.75M
31.53%2.07M
20.88%1.28M
92.24%1.53M
33.51%1.22M
69.47%1.58M
-53.66%1.06M
-30.60%797.48K
-32.95%914.85K
-40.93%930.74K
115.26%2.29M
17.45%1.15M
-24.90%1.36M
-16.90%1.58M
-46.86%1.06M
-56.99%978.40K
-55.27%1.82M
-44.53%1.90M
Total equity
-27.95%2.54M
228.82%5.58M
56.78%5.83M
1.39%6.11M
-60.30%3.53M
-66.00%1.70M
-48.09%3.72M
-34.24%6.02M
-12.41%8.88M
-33.22%4.99M
-58.42%7.17M
-54.39%9.16M
-56.35%10.14M
-70.69%7.47M
-36.64%17.24M
-31.32%20.08M
-25.85%23.24M
11.10%25.49M
392.26%27.21M
343.53%29.24M
Net operating income
-31.53%-3.59M
-29.05%-2.90M
3.28%-3.48M
32.14%-2.27M
-33.24%-2.73M
-5.83%-2.25M
-104.58%-3.60M
-62.07%-3.35M
3.08%-2.05M
14.96%-2.12M
40.80%-1.76M
11.42%-2.06M
-17.26%-2.11M
8.42%-2.50M
-91.54%-2.97M
-6.22%-2.33M
19.64%-1.80M
-19.85%-2.73M
-5419.72%-1.55M
-525.82%-2.19M
Net investment
---500.00K
---850.00K
----
----
----
--0.00
-16.86%-3.24K
----
----
--0.00
---2.78K
----
----
----
----
----
----
----
----
----
Net financing
-94.48%244.78K
444.05%2.98M
208.38%2.86M
184925.81%6.31M
-29.18%4.44M
1889.07%547.58K
1855.95%926.20K
---3.41K
-1.40%6.26M
42.89%-30.61K
-49.65%-52.75K
--0.00
2217.36%6.35M
-140.80%-53.60K
80.97%-35.25K
100.00%0.00
-103.04%-300.00K
-99.24%131.36K
-18.39%-185.18K
-103.49%-23.09K

FAQs

What are the current assets of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its current assets were 5.67M, with a year-on-year change of 202.67.

What are the total assets of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total assets of Processa Pharmaceuticals Inc were 7.81M, with a year-on-year change of 141.96.

What are the total liabilities of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Processa Pharmaceuticals Inc were 2.24M, with a year-on-year change of 45.86.

What is the total equity of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total equity of Processa Pharmaceuticals Inc was 5.58M, with a year-on-year change of 228.82.

What is the net operating income of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Processa Pharmaceuticals Inc was -13.99M, with a year-on-year change of -16.08.

What is the net investment of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net investment of Processa Pharmaceuticals Inc was -850.00K, with a year-on-year change of -26102.22.

What is the net financing of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net financing of Processa Pharmaceuticals Inc was 16.58M, with a year-on-year change of 114.40.

What is the Earnings Per Share (EPS) of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -10.36, with a year-on-year change of 89.30.

What is the net income of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net income was -13.56M, with a year-on-year change of -14.46.

What is the Return on Equity (ROE) of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -372.97, with a year-on-year change of -5.21.

What is the Return on Assets (ROA) of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -245.66, with a year-on-year change of 6.55.

What is the operating profit of Processa Pharmaceuticals Inc?

According to Processa Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -13.99M, with a year-on-year change of -16.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.